Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
20 07 2020
Historique:
received: 01 07 2020
accepted: 01 07 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 13 8 2020
Statut: epublish

Résumé

The COVID-19 epidemic, which began in Wuhan in December 2019, quickly spread all over the world, leading in a few months to a high number of deaths also in healthcare workers. The purpose of the study is to a) describe the importance of a correct management of SARS-CoV-2 infections; b) report the number of positive healthcare workers after the epidemic phase and to describe their socio-characteristics data, the main methods of transmission and the symptoms; c) to report the seroconversion rate of healthcare workers  (HCWs). The study was conducted from March 9, 2020 to June 19, 2020 in three phases:1) in a first phase, we implemented the guidelines to be followed for patient care in our hospital; 2) in a second phase, we provided the epidemiological investigation/contact tracing of HCWs; 3)  we collected swabs on all healthcare workers and we also performed serological investigation. The number of healthcare workers under surveillance is of 2611 subjects and, of these, only 0.65% contracted COVID-19. In particular, 70.6% of these have been infected in the healthcare setting, 11, 8% in the family and 17.6% returning from high risk areas. Ultimately, only 0.1% of HCWs dedicated to the treatment of COVID-19 patients contracted the infection (one was asymptomatic). Only 2% of HCWS were positive for serological investigation.

Identifiants

pubmed: 32701920
doi: 10.23750/abm.v91i9-S.10118
pmc: PMC8023094
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-86

Références

Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
J Infect Public Health. 2018 Jan - Feb;11(1):30-34
pubmed: 28285971
Ann Ig. 2018 Sep-Oct;30(5 Supple 2):86-98
pubmed: 30374514
Vaccine. 2014 Aug 27;32(38):4876-80
pubmed: 24161573
Am J Infect Control. 2016 Dec 1;44(12):1600-1605
pubmed: 27324612
J Prev Med Hyg. 2019 Mar 29;60(1):E12-E17
pubmed: 31041405
Cardiovasc Res. 2020 Oct 1;116(12):1932-1936
pubmed: 32267499
Euro Surveill. 2020 Mar;25(11):
pubmed: 32209163
Vaccines (Basel). 2019 Nov 03;7(4):
pubmed: 31684158
Leg Med (Tokyo). 2019 Feb;36:73-80
pubmed: 30419494
Am J Infect Control. 2014 Mar;42(3):316-20
pubmed: 24581020
Acta Biomed. 2020 Apr 10;91(3-S):175-179
pubmed: 32275287
Lancet Infect Dis. 2020 Jul;20(7):809-815
pubmed: 32330439
Clin Microbiol Infect. 2020 Jul;26(7):954-956
pubmed: 32229288
Lancet Respir Med. 2020 Mar;8(3):e13
pubmed: 32061333
J Public Health Policy. 2020 Sep;41(3):238-244
pubmed: 32472024
Emerg Infect Dis. 2005 Jul;11(7):1142-5
pubmed: 16022801
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Early Hum Dev. 2020 May;144:105026
pubmed: 32247898
Epidemiol Rev. 2019 Jan 31;41(1):69-81
pubmed: 31781765
Euro Surveill. 2020 Feb;25(6):
pubmed: 32046815
Am J Forensic Med Pathol. 2015 Jun;36(2):88-90
pubmed: 25899030
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Lancet Public Health. 2020 Jun;5(6):e310
pubmed: 32339478
Ann Ig. 2019 Mar-Apr;31(2 Supple 1):13-24
pubmed: 30994160
Acta Biomed. 2019 Sep 13;90(9-S):45-53
pubmed: 31517889
Intern Emerg Med. 2013 Dec;8(8):717-23
pubmed: 22249916
New Microbiol. 2018 Jan;41(1):42-46
pubmed: 29313864
Ann Ig. 2016 Sep-Oct;28(5):360-6
pubmed: 27627667

Auteurs

Raffaele Squeri (R)

Department of Biomedical Sciences and Morphological and Functional Images, University of Messina, Messina, Italy. raffaele.squeri@unime.it.

Antonio Levita (A)

Health management, AOU 'G. Martino', Messina, Italy. antonino.levita@polime.it.

Rosanna Intelisano (R)

Health management, AOU 'G. Martino', Messina, Italy. rosanna.intelisano@polime.it.

Gaetano Bruno Costa (GB)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy. gbcosta@unime.it.

Giuseppe Mancuso (G)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. mancusog@unime.it.

Loredana Grasso (L)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. lgrasso@unime.it.

Smeralda D'Amato (S)

Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Italy. damato.esmeralda@libero.it.

Francesco Mazzitelli (F)

Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Italy. francesco88xp@libero.it.

Andrea Squeri (A)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. andreasqueri93@hotmail.it.

Angelina Midiri (A)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. amidiri@unime.it.

Carmelo Biondo (C)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. cbiondo@unime.it.

Domenica Alesci (D)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. dalesci@unime.it.

Vincen Bonaccorso (V)

Department of Human Pathology of the adult and developmental age Gaetano Barresi, University of Messina, Messina, Italy. vbonaccorso@unime.it.

Alessandra Bitto (A)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, Messina, 98125, Italy. abitto@unime.it.

Cristina Genovese (C)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy. crigenovese@unime.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH